Synthesis and Antioxidant Properties of a- and b-Heterylamides
141
TABLE 4. Acute Toxicity and Antioxidant Activity of Compounds
IIIa and Va
EXPERIMENTAL CHEMICAL PART
1
The H and 13C NMR spectra were measured on an
LD50 (mice)
Antioxidant effect:
XL-400 (Varian) spectrometer using CD3OD as the solvent
and TMS as the internal standard. The IR absorption spectra
were recorded on a Specord M-80 spectrophotometer using
samples pelletized with KBr. The course of reactions was
intraperito
Dose,
intragastri
Compound
MDA content,
mM
neal ad-
ministra-
tion
mg/kg
c adminis-
tration
Vitamin E + tetra-
chloromethane
monitored and purity of the reaction products was checked
by TLC on Silufol UV-254 plates (Czech Republic). The
plates were developed by treatment with Bromocresol Blue,
revealing blue spots of imides and yellow spots of amides.
The melting temperatures were determined with the aid of a
Boetius heating table. The yields and physicochemical char-
acteristics of the synthesized compounds are listed in Table 3.
The data of elemental analyses (S, N) of compounds III – V
agree with the results of analytical calculations performed
according to their empirical formulas.
50
25
“
115.0 ± 5.31**
91.3 ± 7.0**
IIIa + tetrachloro-
methane
10000
9000
2300
2000
IVc + tetrachloro-
methane
108 ± 8.20**
85.8 ± 3.22
Intact control
Tetrachloromethane
145.7 ± 6.11*
Notes. Each test group contained five animals.
*
p < 0.05 relative to intact control.
p < 0.05 relative to tetrachloromethane.
**
1,2,2-Trimethylcyclopentane-1,3-dicarboxylic
acid
( æ )-a-N-(5-propyl-1,3,4-thia-2-diazolyl)amide (IIIa). A
mixture of 1.82 g (0.01 mole) of anhydride II, 1.15 g
(0.01 mole) of 2-amino-5-propyl-1,3,4-thiadiazole, and 2 ml
of DMF was boiled for 30 min, cooled, and diluted with two
volumes of water. The precipitate was separated by filtration,
dried, and crystallized from methyl alcohol. Analogous pro-
cedures were used to obtain amides IIIb and IIIc.
model of acute toxic hepatitis induced by intragastric intro-
duction of tetrachloromethane (1 ml of 50% oil solution per
100 g body weight). The compounds studied (in a dose of
25 mg/kg) and the reference drug (vitamin E, 50 mg/kg)
were administered perorally 2 h before and 2 h after intro-
1,2,2-Trimethylcyclopentane-1,3-dicarboxylic
acid
duction of the hepatotoxic agent.
The antioxidant effect was evaluated by the decrease in
( æ )-N-(5-propyl-1,3,4-thia-2-diazolyl)imide (IVa).
M e t h o d A . A mixture of 3.25 g (0.01 mole) of amide
IIIa, 4 ml of glacial acetic acid, and 2 ml of acetyl chloride
was heated on a water bath for 30 min, cooled, and diluted
with two volumes of water. The precipitate was separated by
filtration, dried, and crystallized from methyl alcohol.
M e t h o d B . A mixture of 3.25 g (0.01 mole) of amide
Va, 4 ml of glacial acetic acid, and 2 ml of acetyl chloride
was heated on a water bath for 30 min, cooled, and diluted
with two volumes of water. The precipitate was separated by
filtration, dried, and crystallized from methyl alcohol.
Analogous procedures were used to obtain imides IVb
and IVc.
the malonic dialdehyde (MDA) content in rat liver
homogenates determined according to [6]. The acute toxicity
(LD50) was determined in mice according to [7] for the sub-
stances introduced (in the form of a 3 – 5% aqueous suspen-
sion stabilized with Tween-80) intragastrically or intraperito-
neally in a volume not exceeding 1 ml (Table 4).
REFERENCES
1. G. G. Gatsko, L. M. Mashul’, and O. V. Shablinskaya, Probl.
Endokrinol., 2, 68 – 70 (1985).
1,2,2-Trimethylcyclopentane-1,3-dicarboxylic
acid
2. M. I. Balabolkin, Diabetology [in Russian], Meditsina, Moscow
(2000), p. 672.
( æ )-b-N-(5-propyl-1,3,4-thia-2-diazolyl)amide (Va).
A
mixture of 3.07 g (0.01 mole) of imide IVa and 11.2 ml
(0.02 mole) of a 10% aqueous KOH solution was heated on a
water bath for 2 h, cooled, and acidified with diluted (1 : 1)
HCl to pH 4. The precipitate was separated by filtration,
dried, and crystallized from methyl alcohol. Analogous pro-
cedures were used to obtain amides Vb and Vc (Table 3).
3. S. I. Merzlikin, V. P. Chernikh, and O. P. Gladkikh, Visn.
Farmats., 22(2), 3 – 6 (2000).
4. S. I. Merzlikin, V. P. Chernikh, V. V. Bolotov, et al., Visn.
Farmats., 21(1), 9 – 12 (2000).
5. B. I. Ionov, B. A. Ershov, and A. I. Kol’tsov, NMR Spectroscopy
in Organic Chemistry [in Russian], Khimiya, Leningrad (1983),
p. 268.
6. I. D. Stal’naya and T. G. Garishvili, Modern Methods in Bio-
chemistry [in Russian], Meditsina, Moscow (1977), pp. 44 – 46.
7. V. V. Gatsura, Methods of Primary Pharmacological Character-
ization of Biologically Active Substances [in Russian],
Meditsina, Moscow (1974), p. 114.
EXPERIMENTAL BIOLOGICAL PART
The antioxidant activity of the synthesized compounds
was studied on Wistar rats weighing 175 – 180 g with a